Value of positron emission tomography in diagnosing synchronous penile metastasis from urothelial bladder cancer

World J Surg Oncol. 2015 Sep 17:13:276. doi: 10.1186/s12957-015-0696-1.

Abstract

Metastases to the penis are extremely rare events. Most frequently, penile metastases come from the urogenital system (bladder, prostate) or the rectum-sigmoid colon. Usually painful, penile lesions may be asymptomatic, making diagnosis more challenging. Hence, we report the adding value of (18)F-fludeoxyglucose-positron emission tomography/computed tomography ((18)F-FDG PET/CT) in the detection of penile metastases originating from urothelial carcinoma of the bladder. Arguably, penile metastases must be considered as an advanced disease requiring essentially palliative care. Therefore, accurate staging of clinically localized muscle-invasive bladder cancer is crucial to avoid useless curative intent radical surgery.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Transitional Cell / diagnostic imaging*
  • Carcinoma, Transitional Cell / metabolism
  • Carcinoma, Transitional Cell / secondary
  • Case-Control Studies
  • Female
  • Fluorodeoxyglucose F18 / metabolism*
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Muscle Neoplasms / diagnostic imaging*
  • Muscle Neoplasms / metabolism
  • Muscle Neoplasms / secondary
  • Neoplasm Grading
  • Neoplasm Staging
  • Neoplasms, Multiple Primary*
  • Penile Neoplasms / diagnostic imaging*
  • Penile Neoplasms / metabolism
  • Penile Neoplasms / secondary
  • Positron-Emission Tomography / methods*
  • Prognosis
  • Prospective Studies
  • Radiopharmaceuticals / metabolism
  • Survival Rate
  • Urinary Bladder Neoplasms / diagnostic imaging*
  • Urinary Bladder Neoplasms / metabolism
  • Urinary Bladder Neoplasms / pathology

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18